切换至 "中华医学电子期刊资源库"

中华移植杂志(电子版) ›› 2020, Vol. 14 ›› Issue (02) : 87 -91. doi: 10.3877/cma.j.issn.1674-3903.2020.02.006

所属专题: 文献

移植前沿

国际肺移植临床研究热点和亚洲肺移植发展现状
岳冰清1, 陈静瑜1,()   
  1. 1. 214023 无锡,南京医科大学附属无锡人民医院肺移植中心
  • 收稿日期:2019-12-09 出版日期:2020-04-25
  • 通信作者: 陈静瑜

Summary of the First Wuxi International Lung Transplantation Conference

Bingqing Yue1, Jingyu Chen1,()   

  1. 1. Lung Transplantation Center, Wuxi People′s Hospital Affiliated to Nanjing Medical University, Wuxi 214023, China
  • Received:2019-12-09 Published:2020-04-25
  • Corresponding author: Jingyu Chen
  • About author:
    Corresponding author: Chen Jingyu, Email:
引用本文:

岳冰清, 陈静瑜. 国际肺移植临床研究热点和亚洲肺移植发展现状[J]. 中华移植杂志(电子版), 2020, 14(02): 87-91.

Bingqing Yue, Jingyu Chen. Summary of the First Wuxi International Lung Transplantation Conference[J]. Chinese Journal of Transplantation(Electronic Edition), 2020, 14(02): 87-91.

重点概述首届国际肺移植论坛有关肺移植的临床研究热点和亚洲肺移植发展现状,包括HCV阳性供者供肺应用、肺移植术后并发症的处理、意大利心脏死亡器官捐献经验分享以及亚洲不同地区肺移植经验介绍等。通过国内外专家的经验交流,促进中国肺移植事业与国际接轨并不断发展。

This paper presents a summary of up-to-date knowledge of the First Wuxi International Lung Transplantation Conference. Recent advancement of lung transplantation and current situation of lung transplantation in Asia are introduced, including the application of donor lung from HCV infected donor, the management of complications after lung transplantation, experience sharing of lung transplantation with donor lung from donation after cardiac death in Italy and different parts of Asia, and so on. The exchange of experience of experts at home and abroad promotes the continuous development of lung transplantation in China and to be in line with international standards.

[1]
Carreno MC, Piedad UG, Maite L, et al. Hepatitis C virus infection after lung transplantation: dim prognosis[J]. J Heart Lung Transplant, 2001, 20(2): 224.
[2]
Englum BR, Ganapathi AM, Speicher PJ, et al. Impact of donor and recipient hepatitis C status in lung transplantation[J]. J Heart Lung Transplant, 2016,35(2):228-235.
[3]
D′Ambrosio R, Aghemo A, Rossetti V, et al. Sofosbuvir-based regimens for the treatment of hepatitis C virus in patients who underwent lung transplant: case series and review of the literature[J]. Liver Int, 2016,36(11):1585-1589.
[4]
Khan B, Singer LG, Lilly LB, et al. Successful lung transplantation from hepatitis C positive donor to seronegative recipient[J]. Am J Transplant, 2017,17(4):1129-1131.
[5]
Mansour M, Hill L, Kerr J. Safety and effectiveness of direct acting antivirals for treatment of hepatitis C virus in patients with solid organ transplantation[J]. Transpl Infect Dis, 2018,20(6):e12972.
[6]
Abdelbasit A, Hirji A, Halloran K, et al. Lung transplantation from hepatitis C viremic donors to uninfected recipients[J]. Am J Respir Crit Care Med, 2018,197(11):1492-1496.
[7]
Woolley AE, Singh SK, Goldberg HJ, et al. Heart and lung transplants from HCV-infected donors to uninfected recipients[J]. N Engl J Med, 2019,380(17):1606-1617.
[8]
Van De Wauwer C, Van Raemdonck D, Verleden GM, et al. Risk factors for airway complications within the first year after lung transplantation[J]. Eur J Cardiothorac Surg, 2007,31(4):703-710.
[9]
Yserbyt J, Dooms C, Vos R, et al. Anastomotic airway complications after lung transplantation: risk factors, treatment modalities and outcome-a single-centre experience[J]. Eur J Cardiothorac Surg, 2016,49(1):e1-e8.
[10]
Patterson GA, Todd TR, Cooper JD, et al. Airway complications after double lung transplantation. Toronto Lung Transplant Group[J]. J Thorac Cardiovasc Surg, 1990,99(1):14-20.
[11]
Palleschi A, Tosi D, Rosso L, et al. Successful preservation and transplant of warm ischaemic lungs from controlled donors after circulatory death by prolonged in situ ventilation during normothermic regional perfusion of abdominal organs[J]. Interact Cardiovasc Thorac Surg, 2019, 29(5): 699-705.
[12]
Jo KW, Hong SB, Kim DK, et al. Long-Term outcomes of adult lung transplantation recipients: a single-center experience in South Korea[J]. Tuberc Respir Dis (Seoul), 2019,82(4):348-356.
[1] 陈舜, 薛恩生, 叶琴. PDCA在持续改进超声危急值管理制度中的价值[J]. 中华医学超声杂志(电子版), 2023, 20(09): 974-978.
[2] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[3] 逄世江, 黄艳艳, 朱冠烈. 改良π形吻合在腹腔镜全胃切除消化道重建中的安全性和有效性研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 66-69.
[4] 杨体飞, 杨传虎, 陆振如. 改良无充气经腋窝入路全腔镜下甲状腺手术对喉返神经功能的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 74-77.
[5] 陈垚, 徐伯群, 高志慧. 改良式中间上入路根治术治疗甲状腺癌的有效性安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 619-622.
[6] 曹智, 朱希望, 王尉, 张辉, 杨成林, 张小明. 经皮肾镜碎石取石术中不同肾盂内压力与围术期并发症相关性研究[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 616-620.
[7] 代格格, 杨丽, 胡媛媛, 周文婷. 手术室综合干预在老年腹股沟疝患者中的应用效果[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 759-763.
[8] 王敏, 蒋家斌, 李茂新. 预警宣教联合个性化疼痛管理对腹股沟疝手术患者的影响[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 764-767.
[9] 朱青青, 卫贞祺. 腹股沟疝患者围手术期自我能效管理探讨[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 773-777.
[10] 戴玮, 江桂林, 车兆平, 张姣, 王星星, 赵海涛. 无缝手术护理在腹股沟疝腹腔镜手术围手术期的应用效果[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 778-781.
[11] 潘冰, 吕少诚, 赵昕, 李立新, 郎韧, 贺强. 淋巴结清扫数目对远端胆管癌胰十二指肠切除手术疗效的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 608-612.
[12] 中华医学会骨科分会关节学组. 中国髋、膝关节置换日间手术围手术期管理专家共识[J]. 中华老年骨科与康复电子杂志, 2023, 09(06): 321-332.
[13] 王小娜, 谭微, 李悦, 姜文艳. 预测性护理对结直肠癌根治术患者围手术期生活质量、情绪及并发症的影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 525-529.
[14] 王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[15] 索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.
阅读次数
全文


摘要